Our Global Portfolio for Cardiovascular Health
A Global Leader in Cardiovascular Disease
Amarin is a global pharmaceutical company, focused on addressing cardiovascular health. We apply science, passion, and our global resources to support our BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide and to significantly improve lives.
Amarin at a Glance
Amarin focuses on cardiovascular health on a global scale. Redefining the cardiovascular industry, Amarin boasts a skillful team of passionate employees and leaders – all BOLDLY working toward our vision.
Total revenue earned
Countries where we are
Setting a BOLD Vision into Action
Amarin is setting our BOLD vision into action by providing millions of people worldwide with a cardiovascular disease treatment with proven results. Our products are marketed by Amarin's commercial team and/or sold through commercial partners in numerous key markets throughout the world, with submissions seeking approval of our prescription drug under regulatory reviews in many other countries around the world.
There are numerous traits that make great business leaders, such as being able to encourage others and having a clear vision that others can believe in. At Amarin, we also believe that long-term success can only be achieved through excellent leadership – like our fearlessly BOLD team of executive leaders.
The global market potential for our innovation is substantial. We have an opportunity to make a major impact on arguably the world’s biggest chronic public health challenge - cardiovascular disease.
Karim Mikhail, President & CEO, Amarin